Form 4: Viatris Inc. Officer Paul Campbell Reports Stock Transactions
SEC Form 4
Paul Campbell, a Viatris Inc. officer, reports the vesting and settlement of restricted stock units (RSUs) and performance restricted stock units (PRSUs), along with associated tax withholdings.
Summary
- On March 3rd and 4th, 2025, Paul Campbell, Chief Accounting Officer and Corporate Controller of Viatris Inc., engaged in multiple transactions involving Viatris common stock.
- These transactions primarily involved the vesting and settlement of restricted stock units (RSUs) and performance restricted stock units (PRSUs).
- The transactions also included the withholding of shares to cover tax liabilities associated with the vesting of these units.
- Campbell acquired shares through the vesting of RSUs and PRSUs and disposed of shares to cover tax obligations.
- As a result of these transactions, Campbell's directly held shares of Viatris common stock changed, with the final reported direct holdings totaling 254,140 shares.
- Campbell also holds 318 shares indirectly through a 401(k) plan.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.
Future Outlook
Future vesting dates for RSUs are scheduled for March 3, 2026, and March 4, 2026 and 2027.
Industry Context
This filing is a routine disclosure related to executive compensation and stock-based awards, common in publicly traded companies like Viatris.
Comparison to Industry Standards
- Stock-based compensation is a common practice among pharmaceutical companies like Viatris to incentivize and retain key personnel.
- Companies such as Teva Pharmaceuticals and Novartis also utilize RSUs and PRSUs as part of their executive compensation packages.
- The vesting schedules and terms of these awards are typically detailed in the company's proxy statements and compensation disclosures, allowing for comparison across the industry.
Stakeholder Impact
- The transactions have a minor impact on shareholders, as they relate to executive compensation and do not represent a significant change in the company's financial position.
- Employees who are granted stock-based compensation benefit from the vesting of these awards.
Key Dates
| Date | Description |
|---|---|
| March 3, 2023 | Date of grant for a portion of the restricted stock units (RSUs). |
| March 4, 2022 | Date of grant for a portion of the restricted stock units (RSUs) and performance restricted stock units (PRSUs). |
| March 3, 2024 | Vesting date for a portion of the RSUs granted on March 3, 2023. |
| March 4, 2024 | Date of grant for a portion of the restricted stock units (RSUs). |
| March 3, 2025 | Transaction date for RSU vesting and tax withholding. |
| March 4, 2025 | Transaction date for RSU and PRSU vesting and tax withholding. |
| March 3, 2026 | Future vesting date for a portion of the RSUs granted on March 3, 2023. |
| March 4, 2026 | Future vesting date for a portion of the RSUs granted on March 4, 2024. |
| March 4, 2027 | Future vesting date for a portion of the RSUs granted on March 4, 2024. |
| March 5, 2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.